Profile
Ivan M.
Borrello is the founder of WindMIL Therapeutics, Inc. He is currently the Director at Cellular Therapeutics Ltd. Prior to this, he served as an Independent Director at Gamida Cell Ltd. from 2022 to 2024.
Dr. Borrello completed his undergraduate degree at The Catholic University of America and obtained his doctorate from the Medical College of Virginia.
Ivan Borrello active positions
| Companies | Position | Start |
|---|---|---|
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Director/Board Member | - |
Former positions of Ivan Borrello
| Companies | Position | End |
|---|---|---|
| GAMIDA CELL LTD. | Director/Board Member | 24/05/2024 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Founder | - |
Training of Ivan Borrello
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Catholic University of America
The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Health Technology |
- Stock Market
- Insiders
- Ivan Borrello
















